Dr. Tran's graduate research in organic chemistry focused on developing a stereoelectronic model to explain the stereoselective addition of nucleophiles to oxocarbenium ions to provide substituted tetrahydrofurans. The tetrahydrofuran motif is common in natural products, as well as in synthetic compounds for therapeutic use.
Prior to joining Goodwin, Dr. Tran worked in medicinal chemistry research at Johnson & Johnson Pharmaceutical Research & Development (2005-2008). Her synthetic chemistry background was applied to the discovery of new chemical entities for therapeutic use.
Dr. Tran is a member of the Association for Women in Science and the American Chemical Society.